Tirzepatide (GLP-1/GIP dual agonist), CagriSema (GLP-1/amylin dual agonist), and retatrutide (GLP-1/GIP/glucagon triple agonist) have achieved unprecedented levels of weight loss and glycemic improvement, with certain agents also demonstrating hepatic, cardiovascular, and inflammatory benefits
I did feel a little different, but did not start to lose weight until the beginning of the 3rd week
However, in states of leptin resistance such as obesity, this regulatory mechanism may be impaired (102, 103)
It also improves: weight loss, follicle maturation, menstrual regularity, and reduces excess facial and body hair
Adaptive behavior in autism: minimal clinically important differences on the Vineland-II